Clobenpropit dihydrobromide, H3 antagonist (ab120780)
Key features and details
- Selective H3 antagonist
- CAS Number: 145231-35-2
- Purity: > 99%
- Soluble in water to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Clobenpropit dihydrobromide, H3 antagonist -
Description
Selective H3 antagonist -
Biological description
Selective and competitive H3 antagonist (pKi = 8.5). Partial agonist at H4 receptor (EC50 = 3 nM) Blood-brain barrier permeable.
-
Purity
> 99% -
CAS Number
145231-35-2 -
Chemical structure
Properties
-
Chemical name
N-(4-Chlorobenzyl)-S-[3-(4(5)-imidazolyl)propyl]isothiourea dihydrobromide -
Molecular weight
470.65 -
Molecular formula
C14H17ClN4S.2HBr -
Storage instructions
Store at Room Temperature. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
Source
Synthetic
-
Research areas
Images
-
Chemical Structure - Clobenpropit dihydrobromide, H3 antagonist (ab120780)2D chemical structure image of ab120780, Clobenpropit dihydrobromide, H3 antagonist
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (3)
ab120780 has been referenced in 3 publications.
- Hansen KB et al. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists. J Pharmacol Exp Ther 333:650-62 (2010). PubMed: 20197375
- Dai H et al. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. Eur J Pharmacol 563:117-23 (2007). PubMed: 17350613
- Buckland KF et al. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol 140:1117-27 (2003). PubMed: 14530216